Lit Matters 3: Outcomes for patients with presyncope in ED

Presyncope carries short-term risk much closer to syncope than many clinicians assume. In emergency department presyncope evaluation, 30-day serious outcomes are common enough to justify a syncope-level workup, with disposition guided by risk features, demographics, and the initial ED assessment.

Presyncope Risk and ED Evaluation

• Comparable risk signal: Presyncope is the same symptom complex as syncope minus loss of consciousness, and available evidence suggests its 30-day serious outcome risk is essentially similar rather than reassuringly lower.
• Thirty-day event range: Serious adverse outcomes after ED presyncope fall in a broad range of about 5% to 25%, a high enough signal to treat these patients with real diagnostic caution.
• Cardiac outcomes first: Cardiac events dominate the serious outcomes landscape in presyncope, with arrhythmias such as SVT, sinus node dysfunction, and atrial fibrillation showing up more often than many expect.
• Missed severity bias: Clinicians often perceive presyncope as lower risk than syncope even when outcome rates are similar, a cognitive trap that can soften workup intensity and disposition planning.
• Disposition by risk profile: Not every presyncope patient needs admission, but many need telemetry, ambulatory monitoring, or expedited follow-up based on demographics, risk factors, and the initial evaluation. We get into that disposition nuance in the episode.
• Syncope pathway crossover: A structured risk approach matters here, and syncope tools such as the Canadian Syncope Risk Score can help frame decision-making even when the presenting complaint is presyncope.